Found 1 record.
Displayed record 1
|
1. (CSDB ID: 51865) | report error |
| b-D-GlcpA-(1-3)-+ | a-D-Manp-(1-3)-+ | | | b-D-Xylp-(1-2)-a-D-Manp-(1-4)-a-D-Galp-(1-3)-+ | b-D-GlcpA-(1-3)-+ | | | b-D-Xylp-(1-2)-+ | | | | | b-D-Xylp-(1-3)-a-D-Manp-(1-3)-a-D-Manp-(1-4)-a-D-Galp-(1-3)-+ | | | -6)-b-D-Galp-(1-6)-b-D-Galp-(1-6)-b-D-Galp-(1-6)-b-D-Galp-(1- | Show graphically |
|
Show legend Show as text |
Cryptococcus neoformans
(NCBI TaxID 5207,
species name lookup)
]
jhu.edu>Cryptococcus neoformans was first isolated as a human pathogen in the 1890s. Subsequent study has shown that the polysaccharide capsule of C. neoformans is a key virulence factor. Unlike in bacteria, the pathways for fungal polysaccharide synthesis are not well characterized with only a single glycosytransferase – β-(1,2)-xylosyltranferase Cxt1 – having been confirmed. While there is evidence that polysaccharide synthesis occurs in the cytosol and is transported to the extracellular space in extracellular vesicles, how the capsule attaches to the cell and why some polymers are secreted instead of incorporated into the capsular architecture remains a mystery. In this chapter we explore this along with our current biophysical, structural, and immunological understanding of cryptococcal polysaccharides. From these studies we outline the outstanding questions in the field and identify a bevy of techniques and applications open for future research.
structure, virulence factor, Cryptococcus, glucuronoxylomannan (GXM), fungal polysaccharide
Structure type: polymer chemical repeating unit| New query | Export IDs | Home | Help |
Execution: <1 sec
report error